|
Thursday 21st November 2019 |
Text too small? |
Maxigesic painkiller manufacturer AFT Pharmaceuticals is starting to deliver on the growth strategy funded by its 2015 NZX listing, with sales in South East Asia rocketing ahead in the first six months of this year and in line with company expectations in the six months to Sept. 30. While growth...
Read the full story at BusinessDesk
https://businessdesk.co.nz/article/aft-pharmaceuticals-starts-to-hit-its-straps
No comments yet
PFI - Divestments
CEN offers to purchase remaining 25% of King Country Energy
February 16th Morning Report
SkyCity Appoints Chief Financial Officer
February 13th Morning Report
February 12th Morning Report
NZME 2025 Full Year Results Release Date
Turners Institutional Investor Day
February 10th Morning Report
PEB - Medicare Contractor Novitas Schedules Expert Panel